Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024

February 21, 2024

https://www.globenewswire.com/news-release/2024/02/21/2832729/0/en/Mersana-Therapeutics-to-Host-Fourth-Quarter-and-Year-End-2023-Conference-Call-on-February-28-2024.html

CAMBRIDGE, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will provide business updates and report its financial results for the fourth quarter and full year ended December 31, 2023 on Wednesday, February 28, 2024. The company will host a conference call and webcast at 8:00 a.m. Eastern Time that morning.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.